The Regulatory Role of the Oral Commensal Streptococcus mitis on Human Monocytes. (19th December 2017)

• Record Type: Journal Article
• Authors: Engen, S. A.; Schreurs, O.; Petersen, F.; Blix, I. J. S.; Bækkevold, E. S.; Schenck, K.
• Is Part Of: Scandinavian journal of immunology. Volume 87:Number 2(2018)
• Page Start: 80
• Page End: 87
• Publication Date: 2017-12-19
• Subjects: Immunology -- Periodicals; 571.96
• DOI: 10.1111/sji.12636
• Languages: English
• ISSNs: 0300-9475

Abstract

Abstract: Streptococcus mitis colonizes all niches of the human oral cavity from early infancy and throughout life. Monocytes patrol blood vessels, lymphoid and non‐lymphoid tissues and migrate into infected tissue where they participate in the inflammatory cascade and immune regulation. Here, we studied the effect of S. mitis on monocytes. Transcriptome analysis of monocytes exposed to S. mitis (SmMo) revealed increased transcription of chemotactic factors ( CCL2, CCL3, CCL20, CXCL1, CXCL2 ) and cytokines ( IL1A, IL1B, IL6, IL23, IL36G, TNF ), indicating that S. mitis may trigger recruitment of leucocytes and initiate inflammation. Increased transcription in SmMo of IL1B, IL6 and IL23 indicated that S. mitis may participate in the induction of Th17 responses and agreed with our earlier findings of S. mitis ‐mediated memory Th17 reactivity. Furthermore, S. mitis inhibited tetanus toxoid‐specific CD4 T cell proliferation. This can be due to the increased secretion of IL‐10 and expression of PD‐L1 that was observed in SmMo. PGE2 can modulate IL‐10 and PD‐L1 expression, concomitant with that of CCR7, IL‐12 and IL‐23 that also were changed. This, along with increased SmMo transcription of PTGS2 (COX2) and PTGER4 (EP4), pointed to a role of PGE2. Measurement of PGE2 secretion by SmMo showed indeed a marked increase, and chemical inhibition of PGE2 production lowered the PD‐L1 expression on SmMo. In conclusion, our findings show that S. mitis may trigger immune modulation by recruiting immune cells to the site of infection, while at the same time dampening the severity of the response through expression of IL‐10, PGE2 and PD‐L1.